National Comprehensive Cancer Network



About NCCN

Thyroid Carcinoma Panel - Disclosures as of 4/20/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Douglas W. Ball, MD

None

Exelixis Inc.

None

None

12/7/2011

David Byrd, MD

None

None

None

None

3/4/2013

Raza A. Dilawari, MD

None

Eisai Inc.;
Pfizer Inc.;
Schering-Plough Corporation

None

None

6/6/2011

Gerard M. Doherty, MD

None

Novartis Pharmaceuticals Corporation

None

None

6/2/2011

Quan-Yang Duh, MD

None

None

None

None

6/24/2012

Hormoz Ehya, MD

None

None

None

None

12/11/2012

William B. Farrar, MD

None

None

None

None

6/18/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Robert I. Haddad, MD

None

None

None

None

6/8/2011

Miranda Hughes, PhD

None

None

Myriad Genetic Laboratories, Inc.;
Affymetrix;
Qiagen NV

None

4/10/2013

Jason P. Hunt, MD

None

None

None

None

10/18/2011

Fouad Kandeel, MD, PhD

None

Molecular Insights Pharmaceuticals

None

None

8/17/2012

Richard T. Kloos, MD

None

AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Genzyme Corporation;
Onyx Pharmaceuticals, Inc.

None

American Thyroid Association

12/19/2011

Peter Kopp, MD

None

Abbott Laboratories;
Genzyme Corporation

None

None

8/30/2012

Dominick M. Lamonica, MD

None

None

None

None

6/18/2012

Thom R. Loree, MD

None

None

None

None

6/2/2010

William M. Lydiatt, MD

None

None

None

None

5/2/2012

Judith C. McCaffrey, MD

None

None

None

None

7/26/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Nicole McMillian, MS

None

None

None

None

3/27/2013

Jeffrey F. Moley, MD

None

None

None

None

10/8/2012

John A. Olson, MD, PhD

None

None

None

None

12/3/2009

Lee Parks, MD

None

None

None

None

11/9/2012

John A. Ridge, MD, PhD, FACS

None

None

None

None

3/8/2013

Jatin P. Shah, MD, PhD

None

None

None

None

6/5/2012

Steven I. Sherman, MD

None

AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Eisai Inc.;
Eli Lilly and Company;
Exelixis Inc.;
Oxigene;
Plexxikon;
Semafore;
Veracyte

None

None

8/25/2011

Cord Sturgeon, MD

None

None

None

None

6/18/2012

R. Michael Tuttle, MD

None

Abbott Laboratories;
Eli Lilly and Company;
Genzyme Corporation;
Veracyte

None

None

10/5/2012

Steven G. Waguespack, MD

None

None

None

None

7/24/2012

Thomas N. Wang, MD

None

None

None

None

7/20/2012

Lori J. Wirth, MD

None

Amgen Inc.;
sanofi-aventis U.S.

None

None

4/9/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved